Literature DB >> 9419428

Antigen-presenting cells and the selection of immunodominant epitopes.

J S Blum1, C Ma, S Kovats.   

Abstract

Cellular immune responses are directed against a narrow set of immunodominant peptides derived from complex antigens. By contrast, epitopes that are hidden or infrequent targets of immune responses have been termed cryptic or subdominant. Although the identification of immunodominant epitopes is important for vaccine development, understanding immunological reactivity to cryptic or subdominant epitopes may hold clues to autoimmunity. We have examined the role of antigen-presenting (APC) cells in the selection of class Ii-restricted epitopes for display to T lymphocytes. The formation and MHC-restricted presentation of distinct antigenic epitopes is directly dependent upon processing and ligand binding reactions within APC. A novel MHC heterodimer, HLA-DM, facilitates the binding and presentation of peptides by class II DR, DP, and DQ molecules. We have demonstrated that some epitopes derived from endogenous antigens bind class II proteins independent of DM, whereas the presentation of other endogenous peptides is greatly influenced by DM expression. Targeting of exogenous antigens into specialized processing compartments within APC appears to overcome the requirement for DM in antigen presentation. These studies suggest HLA-DM may play a role in epitope selection and immunodominance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9419428

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  11 in total

1.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 2.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

Review 3.  Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules.

Authors:  Scott A Leddon; Andrea J Sant
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

4.  Revisiting the Principles of Designing a Vaccine.

Authors:  Shubhranshu Zutshi; Sunil Kumar; Prashant Chauhan; Bhaskar Saha
Journal:  Methods Mol Biol       Date:  2022

5.  Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.

Authors:  O Planz; L Stitz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Orchestration of CD4 T cell epitope preferences after multipeptide immunization.

Authors:  Jacqueline Tung; Andrea J Sant
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

7.  Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways.

Authors:  Wolfgang W Leitner; Leroy N Hwang; Michael J deVeer; Aimin Zhou; Robert H Silverman; Bryan R G Williams; Thomas W Dubensky; Han Ying; Nicholas P Restifo
Journal:  Nat Med       Date:  2002-12-23       Impact factor: 53.440

8.  Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.

Authors:  Jason M Weaver; Christopher A Lazarski; Katherine A Richards; Francisco A Chaves; Scott A Jenks; Paula R Menges; Andrea J Sant
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.

Authors:  Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

10.  The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability.

Authors:  Christopher A Lazarski; Francisco A Chaves; Andrea J Sant
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.